Effect of cancer therapy on pituitary-testicular axis

International Journal of Andrology

Volumn 25, Issue 5, 2002, Pages 269-276

  Howell, S J ^a   Shalet, S M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Cancer; Chemotherapy; Fertility; Testicular

Indexed keywords

BLEOMYCIN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; LOMUSTINE; MELPHALAN; PROCARBAZINE; VINBLASTINE;

AZOOSPERMIA; CANCER CHEMOTHERAPY; CANCER THERAPY; CELL FRACTIONATION; CONTROLLED STUDY; CYTOTOXICITY; FERTILITY; GERM LAYER; HUMAN; HYPOPHYSIS TESTIS SYSTEM; INFERTILITY; LEYDIG CELL; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION; REVIEW; SPERMATOCYTE; TESTIS CARCINOMA; TESTIS FUNCTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; DACARBAZINE; DOXORUBICIN; HUMANS; MALE; NEOPLASMS; PITUITARY GLAND; RADIOTHERAPY; TESTIS; VINBLASTINE;

EID: 0036378061     PISSN: 01056263     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2605.2002.00365.x     Document Type: Review

References (48)

1. Aasebo, U., Slordal, L., Aanderud, S. & Aakvaag, A. (1989) Chemotherapy and endocrine function in lung cancer. Acta Oncologica 28, 667-669.
2. Barr, R. D., Clarke, D. A. & Booth, J. D. (1993) Dyspermia in men with localised Hodgkin's disease. A potentially reversible, immune-mediated disorder. Medical Hypotheses 40, 165-168.
3. Bokemeyer, C., Schmoll, H. J., van Rhee, J., Kuczyk, M., Schuppert, F. & Poliwoda, H. (1994) Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma. Annals of Hematology 68, 105-110.
4. Centola, G. M., Keller, J. W., Henzler, M. & Rubin, P. (1994) Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. Journal of Andrology 15, 608-613.
5. Chapman, R. M., Sutcliffe, S. B., Rees, L. H., Edwards, C. R. & Malpas, J. S. (1979) Cyclical combination chemotherapy and gonadal function. Retrospective study in males. Lancet 1, 285-289.
6. Chapman, R. M., Sutcliffe, S. B. & Malpas, J. S. (1981) Male gonadal dysfunction in Hodgkin's disease. A prospective study. Journal of the American Medical Association 245, 1323-1328.
7. Charak, B. S., Gupta, R., Mandrekar, P., Sheth, N. A., Banavali, S. D., Saikia, T. K., Gopal, R., Dinshaw, K. A. & Advani, S. H. (1990) Testicular dysfunction after cyclophosphamide-vincristine-procarbazine-prednisolone chemotherapy for advanced Hodgkin's disease. A long-term follow-up study. Cancer 65, 1903-1906.
8. Chatterjee, R., Mills, W., Katz, M., McGarrigle, H. H. & Goldstone, A. H. (1994) Germ cell failure and Leydig cell insufficiency in post-pubertal males after autologous bone marrow transplantation with BEAM for lymphoma. Bone Marrow Transplant 13, 519-522.
9. Clark, S. T., Radford, J. A., Crowther, D., Swindell, R. & Shalet, S. M. (1995) Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen. Journal of Clinical Oncology 13, 134-139.
10. Clayton, P. E., Shalet, S. M., Price, D. A. & Campbell, R. H. (1988) Testicular damage after chemotherapy for childhood brain tumors. Journal of Pediatrics 112, 922-926.
11. da Cunha, M. F., Meistrich, M. L., Fuller, L. M., Cundiff, J. H., Hagemeister, F. B., Velasquez, W. S., McLaughlin, P., Riggs, S. A., Cabanillas, F. F. & Salvador, P. G. (1984) Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy. Journal of Clinical Oncology 2, 571-577.
12. Giwercman, A., von der Maase, H., Berthelsen, J. G., Rorth, M., Bertelsen, A. & Skakkebaek, N. E. (1991) Localized irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant germ cells in 20 patients. Journal of Clinical Endocrinology and Metabolism 73, 596-603.
13. Guazzieri, S., Lembo, A., Ferro, G., Artibani, W., Merlo, F., Zanchetta, R. & Pagano, F. (1985) Sperm antibodies and infertility in patients with testicular cancer. Urology 26, 139-142.
14. Hahn, E. W., Feingold, S. M. & Nisce, L. (1976) Aspermia and recovery of spermatogenesis in cancer patients following incidental gonadal irradiation during treatment: a progress report. Radiology 119, 223-225.
15. Hansen, S. W., Berthelsen, J. G. & von der Maase, H. (1990) Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance. Journal of Clinical Oncology 8, 1695-1698.
16. Hendry, W., Stedronska, J., Jones, C. C. A. B., Barrett, A. & Peckham, M. (1983) Semen analysis in testicular cancer and Hodgkin's disease: pre- and post-treatment findings and implications for cryopreservation. British Journal of Urology 55, 769-773.
17. Hill, M., Milan, S., Cunningham, D. et al. (1995) Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity [see comments]. Journal of Clinical Oncology 13, 387-395.
18. Howell, S. J., Radford, J. A. & Shalet, S. M. (1999) Testicular function following cytotoxic chemotherapy - evidence of Leydig cell insufficiency. Journal of Clinical Oncology 17, 1493-1498.
19. Howell, S. J., Radford, J. A., Adams, J. E. & Shalet, S. M. (2000a) The impact of mild Leydig cell dysfunction following cytotoxic chemotherapy on bone mineral density (BMD) and body composition. Clinical Endocrinology 52, 609-616.
20. Howell, S. J., Radford, J. A., Smets, E. M. A. & Shalet, S. M. (2000b) Fatigue, sexual function and mood following treatment for haematological malignancy - the impact of mild Leydig cell dysfunction. British Journal of Cancer 82, 789-793.
21. Howell, S. J., Radford, J. A., Adams, J. E., Smets, E. M. A., Warburton, R. & Shalet, S. M. (2001) Randomised placebo controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy. Clinical Endocrinology (Oxford) 55, 315-324.
22. Kinsella, T. J., Trivette, G., Rowland, J., Sorace, R., Miller, R., Fraass, B., Steinberg, S. M., Glatstein, E. & Sherins, R. J. (1989) Long-term follow-up of testicular function following radiation therapy for early-stage Hodgkin's disease. Journal of Clinical Oncology 7, 718-724.
23. Lampe, H., Horwich, A., Norman, A., Nicholls, J. & Dearnaley, D. P. (1997) Fertility after chemotherapy for testicular germ cell cancers. Journal of Clinical Oncology 15, 239-245.
24. Mackie, E. J., Radford, M. & Shalet, S. M. (1996) Gonadal function following chemotherapy for childhood Hodgkin's disease. Medical and Pediatric Oncology 27, 74-78.
25. Meirow, D. & Schenker, J. G. (1995) Cancer and male fertility. Human Reproduction 10, 2017-2022.
26. Meistrich, M. L., Chawla, S. P., Da Cunha, M. F., Johnson, S. L., Plager, C., Papadopoulos, N. E., Lipshultz, L. I. & Benjamin, R. S. (1989) Recovery of sperm production after chemotherapy for osteosarcoma. Cancer 63, 2115-2123.
27. Muller, U. & Stahel, R. A. (1993) Gonadal function after MACOP-B or VACOP-B with or without dose intensification and ABMT in young patients with aggressive non-Hodgkin's lymphoma. Annals of Oncology 4, 399-402.
28. Padron, O. F., Sharma, R. K., Thomas, A. J. Jr & Agarwal, A. (1997) Effects of cancer on spermatozoa quality after cryopreservation: a 12-year experience. Fertility and Sterility 67, 326-331.
29. Palmieri, G., Lotrecchiano, G., Ricci, G., Spiezia, R., Lombardi, G., Bianco, A. R. & Torino, G. (1996) Gonadal function after multimodality treatment in men with testicular germ cell cancer. European Journal of Endocrinology 134, 431-436.
30. Pryzant, R. M., Meistrich, M. L., Wilson, G., Brown, B. & McLaughlin, P. (1993) Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas [published erratum appears in J Clin Oncol 1993 May; 11 (5): 1007]. Journal of Clinical Oncology 11, 239-247.
31. Radford, J. A., Clark, S., Crowther, D. & Shalet, S. M. (1994) Male fertility after VAPEC-B chemotherapy for Hodgkin's disease and non-Hodgkin's lymphoma. British Journal of Cancer 69, 379-381.
32. Rivkees, S. A. & Crawford, J. D. (1988) The relationship of gonadal activity and chemotherapy-induced gonadal damage. Journal of the American Medical Association 259, 2123-2125.
33. Rowley, M. J., Leach, D. R., Warner, G. A. & Heller, C. G. (1974) Effect of graded doses of ionizing radiation on the human testis. Radiation Research 59, 665-678.
34. Sanders, J. E., Hawley, J., Levy, W. et al. (1996) Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 87, 3045-3052.
35. Shalet, S. M., Tsatsoulis, A., Whitehead, E. & Read, G. (1989) Vulnerability of the human Leydig cell to radiation damage is dependent upon age. Journal of Endocrinology 120, 161-165.
36. Shapiro, E., Kinsella, T. J., Makuch, R. W., Fraass, B. A., Glatstein, E., Rosenberg, S. A. & Sherins, R. J. (1985) Effects of fractionated irradiation of endocrine aspects of testicular function. Journal of Clinical Oncology 3, 1232-1239.
37. Shekarriz, M., Tolentino, M. V. Jr, Ayzman, I., Lee, J. C., Thomas, A. J. Jr & Agarwal, A. (1995) Cryopreservation and semen quality in patients with Hodgkin's disease. Cancer 75, 2732-2736.
38. Siimes, M. A., Elomaa, I. & Koskimies, A. (1990) Testicular function after chemotherapy for osteosarcoma. European Journal of Cancer 26, 973-975.
39. Speiser, B., Rubin, P. & Casarett, G. (1973) Aspermia following lower truncal irradiation in Hodgkin's disease. Cancer 32, 692-698.
40. Stuart, N. S., Woodroffe, C. M., Grundy, R. & Cullen, M. H. (1990) Long-term toxicity of chemotherapy for testicular cancer - the cost of cure. British Journal of Cancer 61, 479-484.
41. Vigersky, R., Chapman, R., Berenberg, J. & Glass, A. (1982) Testicular dysfunction in untreated Hodgkin's disease. American Journal of Medicine 73, 482-486.
42. Vilar, O. (1974) Effect of cytostatic drugs on human testicular function. In: Male Fertility and Sterility (eds R. E. Mancini & L. Martini), pp. 423-440. Academic Press, London.
43. Viviani, S., Ragni, G., Santoro, A., Perotti, L., Caccamo, E., Negretti, E., Valagussa, P. & Bonadonna, G. (1991) Testicular dysfunction in Hodgkin's disease before and after treatment. European Journal of Cancer 27, 1389-1392.
44. Viviani, S., Santoro, A., Ragni, G., Bonfante, V., Bestetti, O. & Bonadonna, G. (1985) Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. European Journal of Cancer Clinical Oncology 21, 601-605.
45. Wallace, W. H., Shalet, S. M., Crowne, E. C., Morris Jones, P. H., Gattamaneni, H. R. & Price, D. A. (1989) Gonadal dysfunction due to cis-platinum. Medical Pediatrics Oncology 17, 409-413.
46. Wallace, W. H., Shalet, S. M., Lendon, M. & Morris Jones, P. H. (1991) Male fertility in long-term survivors of childhood acute lymphoblastic leukaemia. International Journal of Andrology 14, 312-319.
47. Watson, A. R., Rance, C. P. & Bain, J. (1985) Long term effects of cyclophosphamide on testicular function. British Journal of Medicine (Clinical research edition) 291, 1457-1460.
48. Whitehead, E., Shalet, S. M., Blackledge, G., Todd, I., Crowther, D. & Beardwell, C. G. (1982) The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male. Cancer 49, 418-422.